help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Long, C. E.
Right arrow Articles by Hall, C. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Long, C. E.
Right arrow Articles by Hall, C. B.

Am. J. Respir. Crit. Care Med., Vol 151, No. 5, 05 1995, 1678-1680.

Sequelae of respiratory syncytial virus infections. A role for intervention studies

CE Long, JT McBride and CB Hall
Department of Pediatrics, University of Rochester Medical Center, NY 14642, USA.

The association between respiratory syncytial virus (RSV) infections in infancy and respiratory abnormalities later in life has been attributed both to a direct effect of the infection itself and to an inherent susceptibility. Observational studies do not allow a rigorous test of these hypotheses. Respiratory syncytial virus infection is universal in the first years of life and no uninfected control group exists. Randomized, controlled trials using new prophylactic agents such as vaccines or specific therapeutic agents will provide a powerful test of the relationship between RSV infection and long-term respiratory sequelae.


This article has been cited by other articles:


Home page
 Arch Pediatr Adolesc MedHome page
N. O. ElHassan, M. E. S. Sorbero, C. B. Hall, T. P. Stevens, and A. W. Dick
Cost-effectiveness Analysis of Palivizumab in Premature Infants Without Chronic Lung Disease.
Arch Pediatr Adolesc Med, October 1, 2006; 160(10): 1070 - 1076.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
A. R. Brasier, H. Spratt, Z. Wu, I. Boldogh, Y. Zhang, R. P. Garofalo, A. Casola, J. Pashmi, A. Haag, B. Luxon, et al.
Nuclear Heat Shock Response and Novel Nuclear Domain 10 Reorganization in Respiratory Syncytial Virus-Infected A549 Cells Identified by High-Resolution Two-Dimensional Gel Electrophoresis
J. Virol., November 1, 2004; 78(21): 11461 - 11476.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. Dakhama, J.-W. Park, C. Taube, K. Chayama, A. Balhorn, A. Joetham, X.-D. Wei, R.-H. Fan, C. Swasey, N. Miyahara, et al.
The Role of Virus-specific Immunoglobulin E in Airway Hyperresponsiveness
Am. J. Respir. Crit. Care Med., November 1, 2004; 170(9): 952 - 959.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
Y. Zhang, M. Jamaluddin, S. Wang, B. Tian, R. P. Garofalo, A. Casola, and A. R. Brasier
Ribavirin Treatment Up-Regulates Antiviral Gene Expression via the Interferon-Stimulated Response Element in Respiratory Syncytial Virus-Infected Epithelial Cells
J. Virol., May 15, 2003; 77(10): 5933 - 5947.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. Bisgaard
A Randomized Trial of Montelukast in Respiratory Syncytial Virus Postbronchiolitis
Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 379 - 383.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
G. Piedimonte and E.A.F. Simoes
Respiratory syncytial virus and subsequent asthma: one step closer to unravelling the Gordian knot?
Eur. Respir. J., September 1, 2002; 20(3): 515 - 517.
[Full Text] [PDF]

Home page
 ChestHome page
D. Edell, V. Khoshoo, G. Ross, and K. Salter
Early Ribavarin Treatment of Bronchiolitis* : Effect on Long-term Respiratory Morbidity
Chest, September 1, 2002; 122(3): 935 - 939.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P. Pala, R. Bjarnason, F. Sigurbergsson, C. Metcalfe, N. Sigurs, and P.J.M. Openshaw
Enhanced IL-4 responses in children with a history of respiratory syncytial virus bronchiolitis in infancy
Eur. Respir. J., August 1, 2002; 20(2): 376 - 382.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
H. Renz and U. Herz
The bidirectional capacity of bacterial antigens to modulate allergy and asthma
Eur. Respir. J., January 1, 2002; 19(1): 158 - 171.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
G. Wennergren and S. Kristjansson
Relationship between respiratory syncytial virus bronchiolitis and future obstructive airway diseases
Eur. Respir. J., December 1, 2001; 18(6): 1044 - 1058.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
E. von Mutius
Infection: friend or foe in the development of atopy and asthma? The epidemiological evidence
Eur. Respir. J., November 1, 2001; 18(5): 872 - 881.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
Y. J. KAO, P. A. PIEDRA, G. L. LARSEN, and G. N. COLASURDO
Induction and Regulation of Nitric Oxide Synthase in Airway Epithelial Cells by Respiratory Syncytial Virus
Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 532 - 539.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
N. SIGURS, R. BJARNASON, F. SIGURBERGSSON, and B. KJELLMAN
Respiratory Syncytial Virus Bronchiolitis in Infancy Is an Important Risk Factor for Asthma and Allergy at Age 7
Am. J. Respir. Crit. Care Med., May 1, 2000; 161(5): 1501 - 1507.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. H. ABERLE, S. W. ABERLE, M. N. DWORZAK, C. W. MANDL, W. REBHANDL, G. VOLLNHOFER, M. KUNDI, and T. POPOW-KRAUPP
Reduced Interferon-gamma Expression in Peripheral Blood Mononuclear Cells of Infants with Severe Respiratory Syncytial Virus Disease
Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1263 - 1268.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1995 American Thoracic Society